DURHAM, N.C., Feb. 20, 2025 (GLOBE NEWSWIRE) — The Society for Clinical Research Sites (SCRS) and Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), are pleased to announce Fortrea’s [...] Read more »
EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
JERUSALEM , Feb. 19, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies in tablet [...] Read more »
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
First patient implanted with Genio at Saudi German Hospital in Dubai, United Arab [...] Read more »
Trident et le ministère des Postes, des Télécommunications et des Technologies numériques de la République démocratique du Congo signent un accord pour la mise en œuvre du Système national d’identité numérique
SINGAPOUR, 12 févr. 2025 (GLOBE NEWSWIRE) — Trident Digital Tech Holdings Ltd (« Trident » ou la « Société », NASDAQ : TDTH), un catalyseur majeur de la [...] Read more »
Trident and the Ministry of Posts, Telecommunications, and Digital Technology of the Democratic Republic of the Congo Sign an Agreement for the Implementation of the National Digital Identity System
SINGAPORE, Feb. 12, 2025 (GLOBE NEWSWIRE) — Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and [...] Read more »
Value of AI, Cloud Solutions Reign in Cellebrite’s 2025 Annual Industry Trends Survey
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 11, 2025 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today [...] Read more »
Cellebrite’s Generative AI Innovations Deliver a Powerful Assistant to Expedite Investigations
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 06, 2025 (GLOBE NEWSWIRE) — Read more »
Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD–19 x FcγRIIb inhibitor of B cell function–
–Topline results from Phase 2 Trial in [...] Read more »
Lantronix Lança LM4, Nova Plataforma Out-of-Band Management Alimentada por IA na Cisco Live
IRVINE, Califórnia, Feb. 05, 2025 (GLOBE NEWSWIRE) — A Read more »
Lantronix stellt auf der Cisco Live erstmals die neue LM4-Out-of-Band-Management-Plattform mit KI-Unterstützung vor
IRVINE, Kalifornien, Feb. 05, 2025 (GLOBE NEWSWIRE) — Read more »